Literature DB >> 9743498

Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1.

L I Bruijn1, M K Houseweart, S Kato, K L Anderson, S D Anderson, E Ohama, A G Reaume, R W Scott, D W Cleveland.   

Abstract

Analysis of transgenic mice expressing familial amyotrophic lateral sclerosis (ALS)-linked mutations in the enzyme superoxide dismutase (SOD1) have shown that motor neuron death arises from a mutant-mediated toxic property or properties. In testing the disease mechanism, both elimination and elevation of wild-type SOD1 were found to have no effect on mutant-mediated disease, which demonstrates that the use of SOD mimetics is unlikely to be an effective therapy and raises the question of whether toxicity arises from superoxide-mediated oxidative stress. Aggregates containing SOD1 were common to disease caused by different mutants, implying that coaggregation of an unidentified essential component or components or aberrant catalysis by misfolded mutants underlies a portion of mutant-mediated toxicity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743498     DOI: 10.1126/science.281.5384.1851

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  340 in total

Review 1.  Molecular mechanisms regulating motor neuron development and degeneration.

Authors:  T J Kilpatrick; M Soilu-Hänninen
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.

Authors:  M D Nguyen; R C Larivière; J P Julien
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

3.  Specificity in intracellular protein aggregation and inclusion body formation.

Authors:  R S Rajan; M E Illing; N F Bence; R R Kopito
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

4.  Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease.

Authors:  B K Vanselow; B U Keller
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

5.  A high-throughput screening method for small-molecule inhibitors of the aberrant mutant SOD1 and dynein complex interaction.

Authors:  Xiaohu Tang; Kathleen I Seyb; Mickey Huang; Eli R Schuman; Ping Shi; Haining Zhu; Marcie A Glicksman
Journal:  J Biomol Screen       Date:  2011-12-01

6.  Intermolecular transmission of superoxide dismutase 1 misfolding in living cells.

Authors:  Leslie I Grad; Will C Guest; Anat Yanai; Edward Pokrishevsky; Megan A O'Neill; Ebrima Gibbs; Valentyna Semenchenko; Masoud Yousefi; David S Wishart; Steven S Plotkin; Neil R Cashman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

7.  Mutant SOD1 forms ion channel: implications for ALS pathophysiology.

Authors:  Michael J Allen; Jérome J Lacroix; Srinivasan Ramachandran; Ricardo Capone; Jenny L Whitlock; Ghanashyam D Ghadge; Morton F Arnsdorf; Raymond P Roos; Ratnesh Lal
Journal:  Neurobiol Dis       Date:  2011-09-10       Impact factor: 5.996

8.  Evaluation of occupational exposure to magnetic fields and motor neuron disease mortality in a population-based cohort.

Authors:  Lauren E Parlett; Joseph D Bowman; Edwin van Wijngaarden
Journal:  J Occup Environ Med       Date:  2011-12       Impact factor: 2.162

9.  Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse.

Authors:  Lijun Wang; Han-Xiang Deng; Gabriella Grisotti; Hong Zhai; Teepu Siddique; Raymond P Roos
Journal:  Hum Mol Genet       Date:  2009-02-19       Impact factor: 6.150

10.  Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models.

Authors:  Per Zetterström; Heather G Stewart; Daniel Bergemalm; P Andreas Jonsson; Karin S Graffmo; Peter M Andersen; Thomas Brännström; Mikael Oliveberg; Stefan L Marklund
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.